Investors Watch List: FibroGen, Inc. (NASDAQ:FGEN), CEL-SCI Corporation (NYSEMKT:CVM), Activision Blizzard, Inc. (NASDAQ:ATVI), Eagle Pharmaceuticals Inc. (NASDAQ:EGRX),

On 29 February, FibroGen, Inc. (NASDAQ:FGEN) reported financial results for the year ended December 31, 2015. Net loss per basic and diluted share for the year ended December 31, 2015 was $1.42 per share.

FibroGen, Inc. (NASDAQ:FGEN) belongs to Healthcare sector. Its net profit margin is -49.30% and weekly performance is 2.79%. On last trading day company shares ended up at $18.77. FibroGen, Inc. (NASDAQ:FGEN) distance from 50-day simple moving average (SMA50) is 0.31%.

CEL-SCI Corporation (NYSEMKT:CVM) announced that during the month of February it has enrolled 27 patients in its ongoing Phase 3 trial of its investigational immunotherapy Multikine* (Leukocyte Interleukin, Injection) in patients with advanced primary head and neck cancer. Total patient enrollment for the trial is now 724 as of February 29, 2016 in the world’s largest Phase 3 study in head and neck cancer.

CEL-SCI Corporation (NYSEMKT:CVM) shares moved up 1.69% in last trading session and ended the day at $0.60. CVM return on assets is -283.90%. CEL-SCI Corporation (NYSEMKT:CVM) quarterly performance is 30.43%.

Activision Blizzard, Inc. (NASDAQ:ATVI) said that, it has been recognized on Fortune’s “100 Best Companies to Work For®” list in 2016.

On 03 March, Activision Blizzard, Inc. (NASDAQ:ATVI) shares moved down -1.53% and was closed at $31.52. ATVI EPS growth in last 5 year was 29.70%. Activision Blizzard, Inc. (NASDAQ:ATVI) year to date (YTD) performance is -18.57%.

On 25 February, Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) announced its financial results for the three- and twelve-month periods ended December 31, 2015. Net income was $1.2 million, or $0.08 per basic and $0.07 per diluted share, compared to a net loss of $5.5 million, or $0.39 per basic and diluted share, for the three months ended December 31, 2014.

Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) belongs to Healthcare sector. Its net profit margin is -7.80% and weekly performance is -1.49%. On last trading day company shares ended up at $65.31. Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) distance from 50-day simple moving average (SMA50) is 31.78%.

Diana Containerships Inc. (NASDAQ:DCIX) reported a net loss of $8.8 million for the fourth quarter of 2015, compared to net income of $0.9 million for the respective period of 2014. The loss for the fourth quarter was mainly the result of $6.6 million of impairment charges of the vessel Hanjin Malta, without which the result for the fourth quarter of 2015 would have been a net loss of $2.2 million.

Diana Containerships Inc. (NASDAQ:DCIX) shares moved up 13.52% in last trading session and ended the day at $0.45. DCIX Gross Margin is 41.70% and its return on assets is -1.90%. Diana Containerships Inc. (NASDAQ:DCIX) quarterly performance is -53.61%.

Leave a Reply

Your email address will not be published. Required fields are marked *